Zobrazeno 1 - 10
of 3 399
pro vyhledávání: '"Human papillomavirus vaccine"'
Publikováno v:
Zhongguo gonggong weisheng, Vol 40, Iss 9, Pp 1110-1116 (2024)
ObjectiveTo analyze the characteristics of adverse events following immunization (AEFI) after the administration of the bivalent human papillomavirus vaccine (HPV2) and the recombinant human papillomavirus 9-valent vaccine (HPV9) in Hebei province, a
Externí odkaz:
https://doaj.org/article/7f0bc5c389484e038f06cf1330c7d641
Autor:
Weiyi Wang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Administering the human papillomavirus (HPV) vaccine to men offers substantial health benefits for both themselves and their female partners. In mainland China, the HPV vaccine has not been approved for men, and little is known about their a
Externí odkaz:
https://doaj.org/article/8b08e28fd10641ed8ecaa54bcea51c54
Autor:
Bruno Julia, Claire Foerst, Sarah Akarkoub, Sarah Azzazene, Nathalie Grémaud, Romain Olivier Sénégas, Benoit Mourlat, Carole Mamane, Lionel Bensimon, Gaëlle Farge
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The vaccine coverage rate (VCR) for human papillomavirus (HPV) in France is one of the lowest in Europe, well below the target of 80% announced in the French Cancer Plan 2021–2030. The extension of vaccination competencies (pres
Externí odkaz:
https://doaj.org/article/f49de5a15d9840158c1ace07f63bda21
Publikováno v:
Pediatric Discovery, Vol 2, Iss 3, Pp n/a-n/a (2024)
Abstract Human Papillomavirus (HPV) is the most common sexually transmitted infection and is associated with cervical, anogenital, and oropharyngeal cancers. It is crucial to improve vaccination uptake in both genders as primary prevention for these
Externí odkaz:
https://doaj.org/article/044186c624ce4563ab4753584dcd6ae0
Publikováno v:
International Journal for Equity in Health, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Inequities in access to human papillomavirus (HPV) vaccine are becoming a growing critical issue globally. Few studies investigate the factors determining HPV vaccine uptake disparities when vaccine supply is constrained, especial
Externí odkaz:
https://doaj.org/article/8393ed7b971d4e97869614752bdce35a
Autor:
Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy
Externí odkaz:
https://doaj.org/article/e0ecfa3e9b9e4e9f9c8ea9e240f6dd5c
Autor:
Tianmeng Wen, Xiaoqian Xu, Chenghao Pan, Shangying Hu, Huan Zhao, Xun Zhang, Youlin Qiao, Fanghui Zhao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
The quadrivalent human papillomavirus (qHPV) vaccine demonstrated high efficacy against vaccine-type-related precancers in Chinese females through a 6.6-year double-blind, randomized control trial (V501–041, NCT00834106). We present results for its
Externí odkaz:
https://doaj.org/article/b7766ab6b70c4b37bc35749bb4679e52
Autor:
Susanne K. Kjaer, Thea E. Hetland Falkenthal, Karin Sundström, Christian Munk, Tina Sture, Oliver Bautista, Sonali Rawat, Alain Luxembourg
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
A pivotal study in women aged 16–26 years demonstrated that the nine-valent human papillomavirus (9vHPV) vaccine was efficacious against high-grade cervical dysplasia related to the HPV types covered by the vaccine. To evaluate whether effectivenes
Externí odkaz:
https://doaj.org/article/a3ca8da01b49464694a4a34ab2a7fce8
Autor:
Ningpei Bai, Qing Wang, Jianchao Shao, Lei Chen, Chenglian Wang, Xiao Xiao, Linling Yu, Binyue Xu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Background: In China, Chongqing is the first province implement a province-wide HPV vaccination free program for female students. Given the HPV vaccination of adolescents is largely dependent on the intent of their guardians, this study examined the
Externí odkaz:
https://doaj.org/article/9f1927b827294889b668333cad034113
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
A rapid review was conducted to explore the implementation determinants of human papillomavirus (HPV) vaccination in the World Health Organization African Region and describe their dynamic relationship. PubMed and Google Scholar were searched in Octo
Externí odkaz:
https://doaj.org/article/b361106420604241a18a5bfaaa3e77c1